EX-12.1 3 a08-11234_1ex12d1.htm EX-12.1

EXHIBIT 12.1

 

United Therapeutics Corporation

Ratio of Earnings to Fixed Charges

(Unaudited)

 

 

 

Three Months Ended
March 31,

 

Years Ended December 31,

 

 

 

 

 

2008

 

2007

 

2006

 

2005

 

2004

 

 

 

(in thousands, except ratio)

 

Earnings from continuing operations before fixed charges

 

$

11,403

 

$

19,859

 

$

28,982

 

$

42,893

 

$

13,209

 

Fixed charges

 

 

 

 

 

 

 

 

 

 

 

Interest expenses, net of capitalized interest

 

$

108

 

$

2,175

 

$

482

 

$

29

 

$

3

 

Capitalized interest

 

601

 

689

 

—

 

—

 

—

 

Portion of rentals representative of interest factor

 

357

 

1,885

 

1,172

 

—

 

—

 

Total fixed charges

 

1,066

 

4,749

 

1,654

 

29

 

3

 

Ratio of earnings to fixed charges

 

10.70

 

4.18

 

17.52

 

1,479.07

 

4,403.00

 

Excess fixed charges over earnings

 

$

—

 

$

—

 

$

—

 

$

—

 

$

—

 

 

NOTE: The Ratio of Earnings to Fixed Charges should be read in conjunction with the Consolidated Financial Statements and related Notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations in United Therapeutics Corporation’s Annual Report on Form 10-K for the year ended December 31, 2007 and the quarterly report on form 10-Q for the three months ended March 31, 2008.